STAGE III CERVICAL CANCER FIGO 2018
Clinical trials for STAGE III CERVICAL CANCER FIGO 2018 explained in plain language.
Never miss a new study
Get alerted when new STAGE III CERVICAL CANCER FIGO 2018 trials appear
Sign up with your email to follow new studies for STAGE III CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine boosts Chemo-Radiation against cervical cancer in early trial
Disease control OngoingThis phase 2 trial tests whether adding a vaccine called PDS0101 to standard chemoradiation is safe and effective for people with advanced cervical cancer. The vaccine trains the immune system to attack HPV-infected tumor cells. About 22 participants will receive the combination,…
Matched conditions: STAGE III CERVICAL CANCER FIGO 2018
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 23:19 UTC
-
Blood test could spot cervical cancer return earlier
Knowledge-focused OngoingThis study looks at whether a blood test can find DNA from the HPV virus that causes cervical cancer. Researchers will collect blood samples from 18 people with cervical cancer before, during, and after treatment. The goal is to see if the test can predict how well treatment work…
Matched conditions: STAGE III CERVICAL CANCER FIGO 2018
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 23, 2026 23:18 UTC